ArticleAesthetic plastic surgery2026
Beauty Under Pressure: The Impact of Hypertension on Outcomes in 54,000 Cases of Esthetic Breast Surgery.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Weight a Minute: Investigating the Impact of Body Mass Index on Early Outcomes After Breast Augmentation.Aesthetic plastic surgery · 2026Article
- Risk Factors for Postoperative Complications After Superomedial Pedicle Reduction Mammaplasty.Aesthetic surgery journal. Open forum · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension affects nearly one-third of the global adult population and is associated with increased postoperative morbidity. However, its specific impact on outcomes of esthetic breast surgery (EBS) remains poorly understood.
methodsData from the multi-institutional American College of Surgeons National Surgical Quality Improvement Program between 2008 and 2022 were analyzed. Patients undergoing elective EBS procedures (breast augmentation, breast reduction, mastopexy, and augmentation-mastopexy) were classified as either medically treated hypertensive (MedHyp) or non-hypertensive (NoMedHyp). 30-day postoperative outcomes were compared between MedHyp and NoMedHyp patients.
resultsA total of 54,336 patients were included, of whom 83.5% (n = 45,373) underwent breast reduction (MedHyp: 7,625 [16.8%] vs. NoMedHyp: 37,748 [83.2%]), 12.1% (n = 6,548) breast augmentation (MedHyp: 209 [3.2%] vs. NoMedHyp: 6,339 [96.7%]), 2.3% (n = 1,237) augmentation-mastopexy (MedHyp: 90 [7.3%] vs. NoMedHyp: 1,147 [92.7%]), and 2.2% (n = 1,178) mastopexy (MedHyp: 136 [11.5%] vs. NoMedHyp: 1,042 [88.5%]). Multivariate analysis revealed a significant association between MedHyp and increased risk of medical complications (OR 1.6, 95% CI 1.1-2.2, p = 0.0070) as well as general (OR 1.5, 95% CI 1.3-1.8, p < 0.001) and any complications (OR 1.2, 95% CI 1.0-1.3, p = 0.0079) after breast reduction. MedHyp was also found to be an independent risk factor for complications after breast augmentation (OR 2.4, 95% CI 1.1-5.1, p = 0.026). No significant associations were observed for mastopexy or augmentation-mastopexy.
conclusionMedically treated hypertension appears to be an independent risk factor for postoperative complications following breast reduction and breast augmentation. These insights underscore the importance of thorough preoperative hypertension management to maximize patient safety and optimize outcomes in EBS. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
40790384What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.